ASPEN PHARMACARE HOLDINGS LIMITED - Dealing in Securities by a Prescribed Officer
What this filing means
Aspen has disclosed an award and immediate vesting of 18,226 ordinary shares to prescribed officer Michael Guy Attridge, made under a post-retirement contract with the company. The shares were delivered off-market on 5 November 2026 at a vesting price of R161.73, a deemed value of R2,947,645.42, based on Aspen's three-day VWAP on 2 November 2026. Clearance was obtained. It is a mechanical share delivery, not a trade the officer chose to make.
Aspen has handed a prescribed officer just over 18,000 shares, worth about R2.9 million at the stated price, as part of a contract he has with the company after retiring. The shares were delivered straight to him rather than bought in the market, so this is paperwork recording a pre-arranged award rather than a sign of what he thinks the share is worth.
Bear case
- Missing evidence: the filing prints no holding or issued-share figure, so the size of the award cannot be measured against the officer's stake or the company's share count.
AI-generated summary by SENS-AI, based on the original JSE SENS filing.
SENS-AI conclusion
No economic signal for outside shareholders. This is a prescribed-officer award that vested and was delivered immediately under a post-retirement contract, recorded for compliance with the JSE Listings Requirements. It tells you nothing about the officer's view of the share price, because he did not choose to buy or sell in the market. The filing also prints no holding or issued-share figure, so the size cannot be measured against anything. So what: nothing changes in the investment case; the operating and cash-flow picture sits in the results and repurchase filings, not here.
No follow-up is needed on this award notice.
Evidence from the filing
The award is a mechanical delivery under a post-retirement contract, not a market trade.
“Nature of transaction : Off-market award and immediate delivery”
The filing gives the award's size in shares and deemed value only.
“Number of securities : 18,226”
The vesting price is set from a three-day VWAP, not a negotiated market price.
“*based on the Aspen 3-day VWAP on 2 November 2026”
More on Aspen Pharmacare Holdings Limited
Related filings
More from APN
- ASPEN PHARMACARE HOLDINGS LIMITED - Grant and Acceptance of Share Awards by Directors, Prescribed Officers and The Company Secretary of Aspen and a Director and the Company Secretary of a Major Subsidiary of Aspen
- ASPEN PHARMACARE HOLDINGS LIMITED - Vesting of Share Awards of Directors, Prescribed Officers and the Company Secretary of Aspen and a Director and the Company Secretary of a Major Subsidiary of Aspen
- ASPEN PHARMACARE HOLDINGS LIMITED - General Repurchase of Ordinary Shares: Subsequent 3% Repurchase
- ASPEN PHARMACARE HOLDINGS LIMITED - Update on the Divestment of a Womens Health Product in Europe to Ennogen
- ASPEN PHARMACARE HOLDINGS LIMITED - Divestment of a Womens Health Product in Europe to Ennogen
Other Director Dealings
- CPICAPITEC LIMITED - Dealing In Securities By A Company Secretary
- TGATHUNGELA RESOURCES LIMITED - Dealing in securities by prescribed officer
- NEDNEDBANK GROUP LIMITED - Dealings in Securities by a Prescribed Officer
- EXPEXEMPLAR REITAIL LIMITED - Dealings in securities by an associate of a director
- BHGBHP GROUP LIMITED - Director/PDMR Shareholding